[1] 苏长海，卢立山. 吸入法治疗哮喘发展史 [J]. 中国药师，2008，11(8)：985-987. [2] Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Vancouver (WA)：Global Initiative for Asthma (GINA);2012. [EB/OL]. [2014-04-02]. http：//www.ginasthma.org/local/uploads/files/GINA_Report _March13.pdf. [3] Global Initiative for Asthma. Global strategy for the diagnosis and management of asthma in children 5 years and younger. 2009. [EB/OL]. [2014-04-02]. http：//www.ginasthma.org/local/uploads/files/GINA_Under5_2009_Cor Aug11_1.pdf. [4] 中华医学会儿科学分会呼吸学组. 中华儿科杂志编辑委员会. 儿童支气管哮喘防治常规（试行）[J]. 2004，42(2)：100-106. [5] 中华医学会儿科学分会呼吸学组. 中华儿科杂志编辑委员会. 儿童支气管哮喘诊断与防治指南 [J].中华儿科杂志，2008，46(10)：745-753. [6] 洪建国. 吸入装置的研究进展 [M]//林江涛，殷凯生.哮喘防治新进展专题笔谈. 北京：人民卫生出版社，2008：206-216. [7] Sbirlea -Apiou G，Katz I，Caillibotte G，et al. Deposition mechanics of pharmaceutical particles in human airways [M]//Hickey AJ. Inhalation Aerosols. New York：Informa Healthcare USA，2007：1-30. [8] Vaghi A1， Berg E， Liljedahl S，et al. In vitro comparison of nebulised budesonide (Pulmicort Respules) and beclomethasone dipropionate (Clenil per Aerosol). Pulm Pharmacol Ther， 2005，18(2)：151-153. [9] Hess DR. Nebulizers：principles and performance [J]. Respir Care，2000，45(6)：609-622. [10] 洪建国，王乃礼. 哮喘的吸入治疗和吸入装置 [J]. 临床儿科杂志，2000，18(3)：185-186. [11] Berg EB，Picard RJ. In vitro delivery of budesonide from 30 jet nebulizer/compressor combinations using infant and child breathing patterns [J]. Respir Care，2009，54(12)：1671-1678. [12] Dolovich MB，Ahrens RC，Hess DR，et al. Device selection and outcomes of aerosol therapy：evidence-based guidelines：American College of Chest Physicians/American College of Asthma，Allergy，and Immunology [J]. Chest，2005，127(1)：335-371. [13] Song IH，Buttgereit F. Non-genomic glucocorticoid effects to provide the basis for new drug developments [J]. Mol Cell Endocrinol，2006，246(1-2)：142-146. [14] 李启先，高兴梅，汪珊. 吸入布地奈德治疗毛细支气管炎 [J]. 安徽医学，2009，30(5)：546-547. [15] 洪建国. 不断提高儿童支气管哮喘的诊治水平 [J]. 中华儿科杂志，2008，46(10)：721-3. [16] Nuhoglu Y，Atas E，Nuhoglu C，et al. Acute effect of nebulized budesonide in asthmatic children [J]. J Investig Allergol Clin Immunol，2005，15(3)：197-200. [17] Castro-Rodriguez GA，Rodrigo GJ. The role of inhaled corticosteroids and montelukast in children with mild-moderate asthma：results of a systematic review with meta-analysis [J]. Arch Dis Child，2010，95（5）：365-370. [18] Szefler SJ，Carlsson LG，Uryniak T，et al. Budesonide inhalation suspension versus montelukast in children aged 2 to 4 years with mild persistent asthma [J]. J Allergy Clin Immunol Pract，2013，1（1）：58-64. [19] McLaughlin T，Leibman C，Patel P，et al. Risk of recurrent emergency department visits or hospitalizations in children with asthma receiving nebulized budesonide inhalation suspension compared with other asthma medications [J]. Curr Med Res Opin，2007，23(6)：1319-1328. [20] Brand PL. Inhaled corticosteroids should be the first line of treatment for children with asthma [J]. Paediatr Respir Rev，2011，12（14）：245-249. [21] British Thoracic Society. Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. A national clinical guideline. 2012. [EB/OL]. http：//www.sign.ac.uk/pdf/sign101.pdf. [22] 陈爱欢，陈荣昌，湛洁谊，等. 雾化吸入高剂量糖皮质激素对儿童中重度支气管哮喘急性发作的疗效 [J]. 中华结核和呼吸杂志，2012，35(4)：269-274. [23] Devidayal， Singhi S， Kumar L，et al. Efficacy of nebulized budesonide compared to oral prednisolone in acute bronchial asthma [J]. Acta Paediatr， 1999，88(8)：835-840. [24] Rivera -Spoljaric K， Chinchilli VM， Camera LJ，et al. Signs and symptoms that precede wheezing in children with a pattern of moderate-to-severe intermittent wheezing [J]. J Pediatr， 2009，154 (6)：877-881. [25] Papadopoulos NG， Arakawa H， Carlsen KH，et al. International consensus on (ICON) pediatric asthma [J]. Allergy， 2012，67 (8)：976-997. [26] Zeiger RS，Mauger D， Bacharier LB，et al. Daily or intermittent budesonide in preschool children with recurrent wheezing [J]. N Engl J Med，2011，365（21）：1990-2001. [27] Todokoro M，Mchizuki H，Tokuyama K，et al. Childhood cough variant asthma and its relationship to classic asthma [J]. Ann Allergy Asthma Immunol，2003，90(6)：652-659. [28] Abouzgheib W，Pratter MR，Bartter T. Cough and asthma [J]. Curr Opin Pulm Med，2007，13(1)：44-48. [29] Matsumoto H，Niimi A，Takemura M，et al. Prognosis of cough variant asthma：a retrospective analysis [J]. J Asthma，2006，43(2)：131-135. [30] Niimi A. Cough and asthma [J]. Curr Respir Med Rev，2011，7(1)：47-54. [31] Takemura M，Niimi A，Matsumoto H，et al. Atopic features of cough variant asthma and classic asthma with wheezing [J]. Clin Exp Allergy，2007，37(12)：1833-1839. [32] 洪建国，成焕吉，谢娟娟，等. 布地奈德雾化吸入治疗儿童咳嗽变异性哮喘研究 [J]. 中国实用儿科杂志，2012，27(4)：270-274. [33] 中华医学会儿科学分会呼吸学组.中华儿科杂志编辑委员会. 中国儿童慢性咳嗽诊断与治疗指南（2013年修订）[J]. 中华儿科杂志，2014，52(3)：184-188. [34] Braman SS. Postinfectious cough：ACCP evidence-based clinical practice guidelines [J]. Chest，2006，129(1 Suppl )：138S-146S. [35] 周静月，任明星，王钟耀，等. 布地奈德雾化吸入预防支原体肺炎后喘息的临床观察 [J]. 临床肺科杂志，2011，16（12）：1954-1956. [36] 沈安英，张建华，全彩琪，等. 阿奇霉素联合雾化吸入治疗肺炎支原体肺炎疗效观察 [J]. 临床肺科杂志， 2014，19(2)： 236-239. [37] Chu HW，Campbell JA，Harbeck RJ，et al. Effects of inhaled fluticasone on bronchial hyperresponsiveness and airway inflammation in Mycoplasma pneumoniae -infected mice [J]. Chest，2003，123(3 Suppl)：427S. [38] Chu HW，Campbell JA，Rino JG，et al. Inhaled fluticasone propionate reduces concentration of mycoplasma pneumo-niae，inflammation，and bronchial hyperresponsiveness in lungs of mice [J]. Infect Dis，2004，189(6)：1119-1127. [39] Griffin S，Ellis S，Fitzgerald-Barron A，et al. Nebulised steroid in the treatment of croup：a systematic review of randomised controlled trials [J]. Br J Gen Pract，2000，50(451)：135-141. [40] Brown JC. The management of croup [J]. Br Med Bull，2002，61：189-202. [41] Johnson D. Croup [J]. Clin Evid (Online)，2009：321. [42] Brown JC，Ausejo M，Saenz A，et al. The effectiveness of glucocorticoids in treating croup：meta-analysis [J]. BMJ，1999，319(7210)：595-600. [43] Griffin S，Godden CW，Campbell MJ，et al. Double blind placebo controlled trial of nebulised budesonide for croup [J]. Arch Dis Child，1997，76(2)：155-158. [44] Roberts GW，Master VV，Staugas RE，et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup [J]. J Paediatr Child Health，1999，35(2)：170-174. [45] Ramanathan R. Optimal ventilatory strategies and surfactant to protect the preterm lungs [J]. Neonatology，2008，93(4)：302-308. [46] Shah SS，Ohlsson A，Halliday HL，et al. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates [DB/OL]. Cochrane Database Syst Rev，2012，5：CD002058. [47] Halliday HL，Patterson CC，Halahakoon CW. A multicenter，randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness：comparison of early and late treatment and of dexamethasone and inhaled budesonide [J]. Pediatrics，2001，107(2)：232-240. [48] Onland W，Offringa M，van Kaam A. Late ( ≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants [DB/OL]. Cochrane Database Syst Reviews，2012，4：CD002311. [49] Maas C，Poets CF，Bassler D. Survey of practices regarding utilization of inhaled steroids in 223 German neonatal units [J]. Neonatology，2010，98(4)：404-408. [50] 张远清，何颜霞，林荣枢. 普米克令舒雾化吸入治疗小儿气管插管导致的喉头水肿 [J]. 实用医学杂志，2006，22(23)：2787-2788.
